Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) CFO Thomas Catinazzo sold 1,695 shares of the business’s stock in a transaction that occurred on Wednesday, January 28th. Thomas Catinazzo also recently made the following trade(s):Get Relay Therapeutics alerts:On Tuesday, January 27th, Thomas Catinazzo sold 13,820 shares of Relay Therapeutics stock. Relay Therapeutics Stock Up 0.8%Relay Therapeutics stock traded up $0.06 during midday trading on Thursday, reaching $7.71. Relay Therapeutics leverages computational modeling, structural biology, and experimental validation to identify small-molecule drug candidates that modulate the behavior of disease-associated proteins. Featured ArticlesReceive News & Ratings for Relay Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relay Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.